This application proposes a multidisciplinary collaborative approach to investigating the intracellular signaling pathways critical to cardiocyte function in human heart failure. The overall application is based on three working hypotheses. First, that abnormalities in calcium cycling proteins and myofibrillar function contribute significantly to the pathogenesis of heart failure. Second, that although the signaling pathways regulating calcium signaling and myofibrillar function can be altered in response to common hemodynamic or humoral stimuli, they are distinct and separable on a molecular level. Third, that somatic gene and/or protein switching transfer will allow us to alter the phenotype of myocytes in human heart failure. Essential to the success of this proposal is the ability to perform manipulations in human cardiac fibers and myocytes. Using adenoviral gene transfer, we can modulate specific signaling pathways of calcium metabolism in human heart failure. Understanding the specific signaling pathways that modulate cardiocyte function, developing approaches to localize modulation of these proteins, and evaluating their functional contribution to the progression of heart failure are the ultimate goals of this R01 competing renewal. We believe the interdisciplinary effort will contribute to an improved understanding of the pathophysiology of heart failure and ultimately, the development of novel therapeutic strategies for this important clinical condition.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL049574-06
Application #
6183014
Study Section
Special Emphasis Panel (ZRG1-CVB (03))
Project Start
1995-06-01
Project End
2003-05-31
Budget Start
2000-06-01
Budget End
2001-05-31
Support Year
6
Fiscal Year
2000
Total Cost
$448,314
Indirect Cost
Name
Gwathmey, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02138
Nagoshi, Tomohisa; Matsui, Takashi; Aoyama, Takuma et al. (2005) PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest 115:2128-38
Lebeche, Djamel; Kaprielian, Roger; del Monte, Federica et al. (2004) In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis. Circulation 110:3435-43
Okafor, Chukwuka; Liao, Ronglih; Perreault-Micale, Cynthia et al. (2003) Mg-ATPase and Ca+ activated myosin AtPase activity in ventricular myofibrils from non-failing and diseased human hearts--effects of calcium sensitizing agents MCI-154, DPI 201-106, and caffeine. Mol Cell Biochem 245:77-89
Communal, Catherine; Huq, Fawzia; Lebeche, Djamel et al. (2003) Decreased efficiency of adenovirus-mediated gene transfer in aging cardiomyocytes. Circulation 107:1170-5
Okafor, Chukwuka C; Saunders, Lori; Li, Xiaoping et al. (2003) Myofibrillar responsiveness to cAMP, PKA, and caffeine in an animal model of heart failure. Biochem Biophys Res Commun 300:592-9
Okafor, Chukwuka C; Perreault-Micale, Cynthia; Hajjar, Roger J et al. (2003) Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure. BMC Physiol 3:6
Cantin, Bernard; Zhu, Dening; Wen, Peizhong et al. (2002) Preferential involvement of larger vessels in a rat model of diabetes-induced graft vasculopathy. J Heart Lung Transplant 21:1040-3
del Monte, Federica; Harding, Sian E; Dec, G William et al. (2002) Targeting phospholamban by gene transfer in human heart failure. Circulation 105:904-7
Del Monte, Federica; Butler, Karyn; Boecker, Wolfgang et al. (2002) Novel technique of aortic banding followed by gene transfer during hypertrophy and heart failure. Physiol Genomics 9:49-56
Cantin, Bernard; Zhu, Dening; Wen, Peizhong et al. (2002) Reversal of diabetes-induced rat graft transplant coronary artery disease by metformin. J Heart Lung Transplant 21:637-43

Showing the most recent 10 out of 31 publications